Compugen Ltd is a biotechnology company that focuses on the discovery and development of novel drug candidates for immuno-oncology and autoimmune diseases

Utilizing its proprietary algorithmic technology platform, the company identifies new therapeutic targets and generates potential antibody candidates. Compugen is engaged in both internal drug development and collaboration with pharmaceutical partners, aiming to enhance treatment options for patients through innovative therapies that leverage the body's immune system to fight cancer and other conditions.